A protein “switch” that activates the immune system to attack cancer cells when it detects signs of the disease has been developed by researchers from the Massachusetts Institute of Technology and the Hebrew University of Jerusalem.
The switch stimulates an immune response only when it detects the cancer cells, without harming other healthy tissues, the researchers said.
The important discovery has just been published in the journal Cell.
Immunotherapy is now seen as having great potential in the research effort to develop drugs against a wide variety of cancers. Despite this success, the use of immunotherapy remains limited due to ...